Jiangsu Jibeier Pharmaceutical Co., Ltd.
688566.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.52B
Close$
$1.05
96.2% downside
Current Fair Value
96.2% downsideOvervalued by 96.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.52 Billion |
|---|---|
| Enterprise Value | $4.94 Billion |
| Dividend Yield | $0.52 (1.89%) |
| Earnings per Share | $1.3 |
| Beta | 0.32 |
| Outstanding Shares | 201,101,625 |
Return
| Return on Equity | 8.29% |
|---|---|
| Return on Assets | 7.50% |
| Return on Invested Capital | 9.13% |
Valuation & Multiples
| P/E Ratio | 26.4 |
|---|---|
| PEG | -61.93 |
| Price to Sales | 6.82 |
| Price to Book Ratio | 2.27 |
| Enterprise Value to Revenue | 4.95 |
| Enterprise Value to EBIT | 20.64 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jiangsu Jibeier Pharmaceutical Co., Ltd.
1,380 employees
CEO: Zhongyi Geng Jiangsu Jibeier Pharmaceutical Co., Ltd. is a pharmaceutical enterprise based in Zhenjiang, China, established in 2001. The company's core operations involve the research, development, manufacturing, and sales of a diverse range of pharm...